Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low molecular weight heparin for unexplained recurrent miscarriage
IRCT2016040327189N1Phase 3Completed
- Sponsor
- Avicenna Research Institute
- Start
- May 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of low molecular weight heparin calcium in recurrent miscarriage (RPL), sponsored by Avicenna Research Institute. Started May 2016; status: completed.
02
Drugs
low molecular weight heparin calcium
03
Conditions
recurrent miscarriage (RPL)
Beyond the preview
Go deeper on IRCT2016040327189N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2016040327189N1.